Measurement of GSK‐3β phosphorylation at Ser9 revealed that Exo‐cur inhibited OA‐induced activation of GSK‐3β while increased AKT expression, thereby preventing Tau phosphorylation via the AKT/GSK‐3β signaling pathway and alleviating cognitive impairments. The gene discussed is AKT1; the disease is Cognitive impairment.